Novo Nordisk A/S (NVO)
128.66
+1.97
(+1.56%)
USD |
NYSE |
May 09, 16:00
128.66
0.00 (0.00%)
Pre-Market: 04:10
Novo Nordisk Total Return Level: 223.86 for May 9, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 09, 2024 | 223.86 |
May 08, 2024 | 220.43 |
May 07, 2024 | 221.48 |
May 06, 2024 | 216.78 |
May 03, 2024 | 214.10 |
May 02, 2024 | 215.79 |
May 01, 2024 | 224.82 |
April 30, 2024 | 223.25 |
April 29, 2024 | 220.76 |
April 26, 2024 | 220.71 |
April 25, 2024 | 218.87 |
April 24, 2024 | 219.51 |
April 23, 2024 | 223.83 |
April 22, 2024 | 217.94 |
April 19, 2024 | 213.51 |
April 18, 2024 | 213.58 |
April 17, 2024 | 216.67 |
April 16, 2024 | 214.80 |
April 15, 2024 | 215.58 |
April 12, 2024 | 216.64 |
April 11, 2024 | 218.19 |
April 10, 2024 | 217.37 |
April 09, 2024 | 217.25 |
April 08, 2024 | 221.77 |
April 05, 2024 | 218.99 |
Date | Value |
---|---|
April 04, 2024 | 215.68 |
April 03, 2024 | 220.95 |
April 02, 2024 | 220.03 |
April 01, 2024 | 221.93 |
March 28, 2024 | 223.41 |
March 27, 2024 | 222.80 |
March 26, 2024 | 225.17 |
March 25, 2024 | 224.54 |
March 22, 2024 | 224.03 |
March 21, 2024 | 224.28 |
March 20, 2024 | 225.19 |
March 19, 2024 | 226.94 |
March 18, 2024 | 229.56 |
March 15, 2024 | 228.66 |
March 14, 2024 | 232.48 |
March 13, 2024 | 230.60 |
March 12, 2024 | 233.40 |
March 11, 2024 | 226.71 |
March 08, 2024 | 229.87 |
March 07, 2024 | 234.80 |
March 06, 2024 | 215.50 |
March 05, 2024 | 215.33 |
March 04, 2024 | 221.03 |
March 01, 2024 | 214.60 |
February 29, 2024 | 206.90 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
37.44
Minimum
May 16 2019
234.80
Maximum
Mar 07 2024
93.50
Average
85.22
Median
Sep 17 2021
Total Return Level Benchmarks
Amgen Inc | 434.89 |
Vertex Pharmaceuticals Inc | 418.99 |
Viking Therapeutics Inc | 80.22 |
Evaxion Biotech AS | 3.77 |
Moderna Inc | 122.69 |